Copeptin in the differential diagnosis of hyponatremia

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 123-129

  Fenske, Wiebke ^a   Störk, Stefan ^a   Blechschmidt, Anne ^a   Maier, Sebastian G K ^a   Morgenthaler, Nils G ^b   Allolio, Bruno ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BRAHMS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; DIURETIC AGENT; SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERVOLEMIA; HYPONATREMIA; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; POLYDIPSIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URINE OSMOLALITY;

EID: 58149381999     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1426     Document Type: Article

References (34)

1. Kumar S, Berl T 1998 Sodium. Lancet 352:220-228
2. Upadhyay A, Jaber BL, Madias NE 2006 Incidence and prevalence of hyponatremia. Am J Med 119:S30-S35
3. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH 2007 Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 120:S1-S21
4. Chung HM, Kluge R, Schrier RW, Anderson RJ 1987 Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 83:905-908
5. Schrier RW 2006 Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17:1820-1832
6. Anderson RJ, Chung HM, Kluge R, Schrier RW 1985 Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102:164-168
7. Schrier RW, Berl T, Anderson RJ 1979 Osmotic and nonosmotic control of vasopressin release. Am J Physiol 236:F321-F332
8. Robertson GL 1994 The use of vasopressin assays in physiology and pathophysiology. Semin Nephrol 14:368-383
9. Cadnapaphornchai MA, Summer SN, Falk S, Thurman JM, Knepper MA, Schrier RW 2003 Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am J Physiol Renal Physiol 285:F965-F971
10. Morgenthaler NG, Struck J, Alonso C, Bergmann A 2006 Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
11. Jochberger S, Morgenthaler NG, Mayr VD, Luckner G, Wenzel V, Ulmer H, Schwarz S, Hasibeder WR, Friesenecker BE, Dunser MW 2006 Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 91:4381-4386
12. Robertson GL, Mahr EA, Athar S, Sinha T 1973 Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52:2340-2352
13. Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB 1983 Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5:I129-138
14. Holwerda DA 1972 A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur J Biochem 28:334-339
15. Holwerda DA 1972 A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary structure. Eur J Biochem 28:340-346
16. Struck J, Morgenthaler NG, Bergmann A 2005 Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500-2504
17. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Muller B, Keller U, Christ-Crain M 2007 Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 92:3973-3978
18. Morgenthaler NG, Struck J, Jochberger S, Dunser MW 2008 Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43-49
19. McGee S, Abernethy 3rd WB, Simel DL 1999 The rational clinical examination. Is this patient hypovolemic? JAMA 281:1022-1029
20. Schwartz WB, Bennett W, Curelop S, Bartter FC 2001 A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol 12:2860-2870
21. Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A 1993 X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92:1262-1268
22. Hanley JA, McNeil BJ 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
23. Robertson GL, Athar S 1976 The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 42:613-620
24. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C 2007 Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18:606-612
25. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE 2005 Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352:1884-1890
26. Verbalis JG 2003 Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 17:471-503
27. Schrier RW 2007 The sea within us: disorders of body water homeostasis. Curr Opin Investig Drugs 8:304-311
28. Chow KM, Kwan BC, Szeto CC 2004 Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc 96:1305-1308
29. Sonnenblick M, Algur N, Rosin A 1989 Thiazide-induced hyponatremia and vasopressin release. Ann Intern Med 110:751
30. Friedman E, Shadel M, Halkin H, Farfel Z 1989 Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 110:24-30
31. Robertson GL 2006 Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119:S36-S42
32. Ellison DH, Berl T 2007 Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356:2064-2072
33. Zerbe R, Stropes L, Robertson G 1980 Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315-327
34. Soupart A, Gross P, Legros JJ, Alfoldi S, Annane D, Heshmati HM, Decaux G 2006 Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol 1:1154-1160